Financial Statements Analysis
Financial Statements Analysis
436 PERD CO
page 174
STATEMENT OF PROFIT AND LOSS STATEMENT OF FINANCIAL POSITION
FOR THE YEAR ENDED 31 MARCH 20X8 FOR THE YEAR ENDED 31 MARCH 20X8
Adjustments W0 NCI
1- PAT 3690
unwinding of interest 452.82 depreciatio -100
profit on d -2700
2- take 300 the current year impairment to nci w0 and spl impairmen -300
and total balance of 700 to sofp 590
3- nci share 118
dr asset 3000 total comp 1290
cr gain 3000 nci share 258
433 GOLD CO
page 170
Part B
CONSOLIDATED STATEMENT OF PROFIT AND LOSS
FOR THE YEAR ENDED 30 SEPT 20X2
adj 2
dr asset 2600
cr gain 2600 w1
5-
800 associate dividend minus from investment income
1200 associate pat minus before pbit
432 PLANK CO
STATEMENT OF PROFIT AND LOSS
FOR THE YEAR ENDED 31 DEC 20X8
parent sub 9/12
Revenue 705000 163500 -39000 829500 Part B
Cos 320000 60750 -32650 348100 INVESTMENT IN ASSOCIATE
Gross profit 481400 carrying amount of investment
Distribution cost 58000 12000 70000 pat share
Admin expenses 92000 21000 113000 less urp
investment income 46000 1500 32550 14950 less dividend
associate pat 32399.5
finance cost 12000 6750 18750
PBT 326999.5
tax expense 51500 11250 62750
PAT 264249.5
PARENT SHARE 257312
NCI SHARE 6937.5
OCI
gain on revaluation 2800 3000 5800
TOCI 270049.5
PARENT SHARE 262662
NCI SHARE 7387.5
ADJUSTMENTS NCI W0
1 dr asset 8000 share of pat and oci
cr gain 8000 PAT TOCI
interest ad 53250
dr dep 2000 cos dep -2000
cr asset 2000 gain
interest po -5000
2 intra group sales
dr sales 39000 46250
cr cos 39000 6937.5 450
subsidary --->
urp
dr profit 9750 2250
cr inventory 2250
urp
dr profit 2100
cr inventory 2100
3 dr interest income 5000 post acq interest from parent to sub so must be removed fro
cr interest liab 5000
431 RUNNER CO
PAGE 167
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
FOR THE YEAR 31 MARCH 20X4
W1 GOODWILL adjustments
Consideration paid 42500 2 dr asset 10000
deffered consideratio 19446 cr gain 10000
Nci at fair value 13000
dr dep 1000
less sub net assets at acq cr asset 1000
share capital 25000
retained earnings 19500 3 dr profit 720
fair value gain 10000 cr inventor 720
7380
Parent Nci
5904 1476
NCI W3
Nci fv 13000
sub consol 1476
14476
430 PARTY CO
page 166 CONSOLIDATED STATEMENT OF FINANCIAL POSITION
FOR THE YEAR ENDED 30 SEPT 20X5
647556
W1 GOODWILL Adjustments
Consideration paid 1
initial cash 92000 dr investment in sub
deffered consideratio 23996 cr deffered liab
Nci at fair value 15000
unwinding of interest
Less sub net assets at acq dr interest exp
share capital 60000 cr deffered liab
retained earning 34000
revaluation surplus 4000 2 dr inventory
gain 600 cr gain
98600
dr profit
GOODWILL 32396 cr inventory
3 dr profit
W2A CONSOLIDATED RETAINED EARNING cr inventory
retained oci
parent ret 210000 41400
urp -250
deffered in -1919.68
w2b 1568
209398.3 41400
1960
w2a 392
1568 nci
W3 NCI
fair value 15000
w2b 392
15392
437 DOBRY
Page 176 CONSOLIDATED STATEMENT OF FINANCIAL POSIT
FOR THE YEAR ENDED 31 DEC 20X6
less sub net assets at acq less sub net assets at acq
share capital 100000 share capital 100000
revaluation 15000 gain acq 24000
retained earning 30000 retained earning 16000
48500 10000
parent sha 38800 12000 7500
nci 9700 3000 2500
W3 NCI
nci at fv 74000
krol 9700
henz 2500
impairment -1600
revaluation 3000
87600
CHANG CO
434 CONSOLIDATED STATEMENT OF PROFIT AND LOSS
PAGE 172
CHANG CO SING CO
Revenue 51680 22800 -2700
Cos 30960 15600 -2100
Gp
distribution 1280 1117.5
admin expense 3040 1402.5 1000
investment income 0
PAT FROM ASSO
finance 336 1028.242
PBT
tax 2240 960
PAT
NCI
PARENT
W1 GOODWILL ADJUSTMENTS
consideration paid working
Consideration paid 47360.13 dr investment in sub
cr cash
nci at fv 7728
dr investment in sub
less sub net asset at acq cr deffered consideration
share capital
retained earning 29240 dr interest exp
gain 1800 cr deffered liability
contingent liab -400
share capital 8000 1-
38640 retained earning
pat 1240
AT ACQ GOODWILL 16448.13 given 28000
acq retain 29240
impairment 1000 post acq 32960
dr sales
cr cos
6 convertible loan
5000
y5
DARGENT CO
STATEMENT OF FINANCIAL POSITION
FOR THE YEAR ENDED 31 MAR 20X6
W1 GOODWILL ADJUSTMENTS
Consideration paid 47000 dr investm 32000
cr share ca 10000
NCI 9000 cr share p 22000
dr investm 15000
less subsidiary net asset at acq cr deffered 15000
share capital 26000
retained earning 19000 unwinding
fair value 4000 dr interest 300
provision -4000 cr deffered 300
45000
1
11000 dr mine asse
cr provision
w2a
retained 36000 dr dep
unwinding -300 cr mine
urp -800
1290 dr interest exp
associate p 1800 cr provision
associate d -600
37390 3
w2b
retained earning 2000
dep -200
provison -80
1720
1290 430
4
W3 NCI associate pat
9000
w2b 430
9430
associate dividend
LAUREL
CONSOLIDATED STATEMENT OF PROFIT AND LOSS
FOR THE YEAR ENDED 30 SEPT 20X6
Parent sub total
Revenue 84500 39000 -10800 112700
Cos 58200 25500 -8800 74900
Gross profit 37800
Distribution cost 2000 1200 3200
Administrative expenses 4100 2100 6200
Investment income 0 300 300
Finance cost 300 810.0648 1110
associate pat 600
PBT 28190
tax 4800 2700 7500
PAT 20690
parent share 18370
nci 2320
ADJUSTMENTS
1 dr plant
W1 GOODWILL AT ACQ cr gain
consideration paid 51301.08
dr dep
nci value at fair value 12000 cr asset
46800 dr urp
cr inventory
16501.08
4 dividend
PAGE PANDAR
420 CONSOLIDATED STATEMENT OF PROFIT OR LOSS
parent sub total
Revenue 210000 75000 -15000 270000
Cos 126000 50000 -13260 162740
Gross profit 107260
Distribution 11200 3500 14700
administrative expenses 18300 4500 5000 27800
Investment income 9500 -8400 1100
finance costs 1800 500 2300
associate loss -1000
PBT 62560
tax -15000 -5000 -20000
PAT 42560
Parent share 41160
NCI 1400
ADJUSTMENT
1 dr asset
cr gain
dr dep
cr asset
3 dividend
4 dr sales
cr cos
dr urp
cr inventory
5 impairment
sub
associate
associate pat
PART A
Carrying amount of investment
cost 32000 consideration paid 32000
share of po -1000
less urp if -240
less impai 3000
27760
421 PRODIGAL
PAGE 152 CONSOLIDATED STATEMENT OF PROFIT AND LOSS
PBT 181000
tax 48000 13900 61900
PAT 119100
Parent share 111550
NCI 7550
ADJUSTMENT
W2A CONSOLIDATED RETAINED EARNING 1 dr asset
retained oci cr gain
179900 10900
urp -1000 2
w2a 22650 750
EQUITY PART
321000
PALADIN
422 CONSOLIDATED STATEMENT OF FINANCIAL POSTION
PAGE 153 FOR THE YEAR ENDED 30 SEPT 20X1
W1 ADJUSTMENTS
GOODWILL dr investment consideration
consideration paid 32000 cr cash
deffered consideratio 5000
NCI at fair value 7000 dr investment consideration
cr deffered consideration
less sub net assets at acq
equity share 10000 dr interest exp
retained earning 12000 cr deffered consideration
gain 4000
ammortization 3000 dr investment in aia
29000 cr cash
GOODWILL 15000 associate pat
dr investment in associate
w2a cre cr cre w2a
retained earning 34900
associate pat 200 2 dr asset 4000
urp -600 cr gain 4000
associate impairment -2500
w2b 3600 dr dep 1000
deffered interest -400 cr asset 1000
35200
W2B dr ammortization
retained earning 6000 cr intangible
dep -1000 3 dr urp 600
-500 cr inventor 600
4500 4 associate
nci 900 dr impairment
parent 3600 cr invest in associate
W3 NCI
fair value 7000
w2b 900
7900
PAT
unwinding of interest
dr interest exp 2376.024 w2a
cr deffered liab 2376.024
sofp
additonal charge to spl
INVESTMENT IN ASSOCIATE
mount of investment 145000
32399.5
2100
12250
163049.5
sub so must be removed from sub finance cost before time apportion
117001.7
624926
w1
w2b
w2b
L POSITION
190000
ed retained earning 209398.3
41400
15392
onsideration 25915.68
165450
647556
unwinding of interest
dr interest exp 1919.68 w2a
cr deffered liab 1919.68
600
600 w1
540 w2b
540
250 w2a
250
EMENT OF FINANCIAL POSITION
D 31 DEC 20X6
ENT LIABILITY
500000
270700
12000
87600
870300
448000
87200
1405500
ADJUSTMENT
2
dr asset 24000
cr gain 24000 w1
dr payable 18000
cr receivab 18000
EMENT OF PROFIT AND LOSS
TOTAL
71780
44460
27320
2397.5
5442.5
0
300
1364.242
18415.76
3200
15215.76
624
14591.76
on paid working
34560
34560
12800.13
consideration 12800.13
960.0096
960.0096
1800
1800 w1
450
450 post
150
150 post
2700
2700
convertible loan
50000
300
20000
dr interest exp 300
4080
current liab 38100
191300
ADJUSTMENTS
w2a
4000 w1
4000
200 w2b
200
dr interest exp 80
cr provision 80
dr urp 800
cr inventor 800
dr pay 2300
dr inv 700
cr rec 3000
associate pat
dr invest in associate 1800
cr cre w2a 1800
associate dividend
dr cash 600 w2a
cr invest in associate 600
ADJUSTMENTS considerations
4000 dr cash 37800 dr inv 13501.08
4000 w1 cr share ca 5400 cr deffered13501.08
cr share p 32400
1500 w2b dr interest 810.0648
1500 cr deffere 810.0648
10800
10800
300 w2b
300
associate dividend 50 since this owned for many years no entry for this
OF PROFIT OR LOSS
ADJUSTMENT W0
5000 nci 10500
5000 w1 dr dep -500
urp -1000
500 cos w0 sub -2000
500 7000
1400
intra group interest
dr interest income 2000
cr interest expense 2000
15000
15000
1000
1000
2000
3000
associate pat
-1000
F PROFIT AND LOSS
oci
rev gain 2500 1000 3500
TOCI 122600
parent share 114800
nci 7800
200
200 w2b
40000
40000
profit
3000 w2b
3000
FINANCIAL POSTION
D 30 SEPT 20X1
141800
acquired 80
32000
32000
5000
5000
400 w2a
400
10000
10000
200
200
w1
w2b
2500 w2a
2500